September 2015

Join WhatsApp Channel 

Crack GPAT — Prepare for GPAT Online
Opportunity for B.Pharm/M.Pharm, MBA as Product Executive (PMT) in Optho Remedies | 4 Posts

Optho Remedies P Ltd with 40 years of strong  in ophthalmic manufacturing & marketing. Optho Has a strong and sturdy team  across the length & breath of the country.

Post: Product Executive

Walk in for Pharmacist, Assistant Pharmacist in HLL Lifecare

HLL Lifecare Limited (formerly Hindustan Latex Limited) India’s leading manufacturers and marketers of Contraceptive, Health Care and Pharma products is a Mini Ratna Company under the Ministry of Health & Family Welfare, Govt. of India, with seven manufacturing units and Marketing offices throughout the country.

HLL is on the lookout for dynamic, result oriented, performance driven Pharmacists having good track record in the relevant field. Postings shall be done on Fixed term contract basis and emoluments will be fixed depending upon qualifications, skills and experience.

Post: Pharmacist, Assistant Pharmacist

Application are invited for Pharmacist (Allopath) in NHM, Tripura | 6 Opening

Application in plain paper is hereby invited for filling up the following posts on contractual basis at a fixed pay as shown against each for District Health & Family Welfare Society, South Tripura. It will be purely contract basis for a period of 11 (Eleven) months likely to be extended based on performance of employees till the project period only.

The selection of the candidate will be done through the competency assessment and interview.

Post: Pharmacist (Allopath)

One day workshop on Awareness of Indian Pharmacopoeia and Indian Pharmacopoeia Reference Standards (IPRS) At Pharmacy & Technology Management, SVKM’s NMIMS, Mumbai on 07th October 2015

SVKM’s NMIMS Deemed to be University (as per UGC Norms), one of the premier Universities of Higher Studies in India, has completed 33 years of its existence in the year 2013-14. NMIMS established in the year 1981 as Narsee Monjee Institute of Management Studies, began its journey by offering a masters degree program in management studies...

  • Interim analysis of INPULSIS®-ON study shows: Beneficial effect of OFEV®* on slowing disease progression was maintained and the change from baseline in FVC was consistent over 2 years
  • Long-term treatment with OFEV®* had a manageable safety and tolerability profile (mean exposure of 2.4 years, maximum exposure of more than 3 years)
  • Commonly used concomitant medications, such as anti-acids or systemic steroids, do not influence the beneficial effect of OFEV®* on slowing disease progression
PharmaTutor Magazine - October 2015 is released | Subscribe today
PharmaTutor Magazine | October 15

A new study suggests that the survival rate of premature babies born between 26 to 31 weeks of gestation can be improved by blocking light from reaching the intravenously-fed infused nutritious mixture for survival. The study was published in the Journal of Parenteral and Enteral Nutrition.